{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:07:23Z","timestamp":1791220043237,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jaut.2024.103301","type":"journal-article","created":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T03:46:10Z","timestamp":1723779970000},"page":"103301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Safety of biologic immunosuppressants in pregnant women with immune-mediated inflammatory diseases"],"prefix":"10.1016","volume":"148","author":[{"given":"Mart\u00ednez-S\u00e1nchez","family":"N","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"\u00c1lvarez-Troncoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1.","family":"Robles-Marhuenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"De la Calle Fern\u00e1ndez-Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.","family":"Muner Hernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"Bartha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jaut.2024.103301_bib1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review","volume":"142","author":"Molodecky","year":"2012","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.jaut.2024.103301_bib2","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/acr.21900","article-title":"Incidence of rheumatoid arthritis in Sweden: a nationwide population-based assessment of incidence, its determinants, and treatment penetration","volume":"65","author":"Eriksson","year":"2013","journal-title":"Arthritis Care Res."},{"issue":"4","key":"10.1016\/j.jaut.2024.103301_bib3","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/rheumatology\/ket387","article-title":"Global prevalence of ankylosing spondylitis","volume":"53","author":"Dean","year":"2013","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.jaut.2024.103301_bib4","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.3390\/nu14081591","article-title":"Inflammatory bowel disease and reproductive health: from fertility to pregnancy\u2014a narrative review","volume":"14","author":"Ronchetti","year":"2022","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.jaut.2024.103301_bib5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/03009742.2020.1849788","article-title":"Pregnancy outcome in women with different rheumatic diseases: a retrospective analysis","volume":"50","author":"Eisfeld","year":"2021","journal-title":"Scand. J. Rheumatol."},{"issue":"5","key":"10.1016\/j.jaut.2024.103301_bib6","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","article-title":"The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation","volume":"75","author":"G\u00f6testam Skorpen","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.jaut.2024.103301_bib7","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1093\/rheumatology\/kev404","article-title":"BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding\u2014Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids","volume":"55","author":"Flint","year":"2016","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.jaut.2024.103301_bib8","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/17512433.2017.1305268","article-title":"The use of biologics in pregnant patients with rheumatic disease","volume":"10","author":"\u00d8stensen","year":"2017","journal-title":"Expet Rev. Clin. Pharmacol."},{"issue":"Suppl 3","key":"10.1016\/j.jaut.2024.103301_bib9","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","article-title":"British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults","volume":"68","author":"Lamb","year":"2019","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.jaut.2024.103301_bib10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ad.2020.10.002","article-title":"Management of psoriasis during preconception, pregnancy, postpartum, and breastfeeding: a consensus statement","volume":"112","author":"Belinch\u00f3n","year":"2021","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas"},{"issue":"4","key":"10.1016\/j.jaut.2024.103301_bib11","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/acr.24130","article-title":"American college of rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Care Res."},{"issue":"4","key":"10.1016\/j.jaut.2024.103301_bib12","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1093\/rheumatology\/keac551","article-title":"British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids [published correction appears in Rheumatology (Oxford). 2022 Dec 13","volume":"62","author":"Russell","year":"2023","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.jaut.2024.103301_bib13","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/uog.22134","article-title":"ISUOG Practice Guidelines: diagnosis and management of small-for-gestational-age fetus and fetal growth restriction","volume":"56","author":"Lees","year":"2020","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.jaut.2024.103301_bib14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41581-019-0119-6","article-title":"Pre-eclampsia: pathogenesis, novel diagnostics and therapies","volume":"15","author":"Phipps","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jaut.2024.103301_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.887462","article-title":"Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis","volume":"13","author":"Gerardi","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.jaut.2024.103301_bib15","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/MCG.0000000000001244","article-title":"Noninvasive methods for assessing inflammatory bowel disease activity in pregnancy","volume":"53","author":"Tandon","year":"2019","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.jaut.2024.103301_bib16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejim.2020.03.015","article-title":"Clinical utility of fecal calprotectin in monitoring disease activity and predicting relapse in pregnant patients with inflammatory bowel diseases","volume":"77","author":"Rottenstreich","year":"2020","journal-title":"Eur. J. Intern. Med."},{"issue":"18","key":"10.1016\/j.jaut.2024.103301_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810281","article-title":"Elevated IL-6 and IL-22 in early pregnancy are associated with worse disease course in women with inflammatory bowel disease","volume":"23","author":"Wu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.jaut.2024.103301_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ogc.2014.09.005","article-title":"Age-related infertility","volume":"42","author":"Crawford","year":"2015","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"issue":"1","key":"10.1016\/j.jaut.2024.103301_bib20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.berh.2016.05.002","article-title":"Pregnancy and autoimmune connective tissue diseases","volume":"30","author":"Marder","year":"2016","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"2","key":"10.1016\/j.jaut.2024.103301_bib21","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.siny.2017.11.005","article-title":"First and second trimester screening for fetal structural anomalies","volume":"23","author":"Edwards","year":"2018","journal-title":"Semin. Fetal Neonatal Med."},{"issue":"5","key":"10.1016\/j.jaut.2024.103301_bib22","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1093\/ecco-jcc\/jjz211","article-title":"Inflammatory bowel disease and risk of birth defects in offspring","volume":"14","author":"Auger","year":"2020","journal-title":"Journal of Crohn\u2019s and Colitis"},{"issue":"6","key":"10.1016\/j.jaut.2024.103301_bib23","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1007\/s00404-022-06463-x","article-title":"Pregnant women with immune mediated inflammatory diseases who discontinue biologics have higher rates of disease flare","volume":"306","author":"Allen","year":"2022","journal-title":"Arch. Gynecol. Obstet."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841124001355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841124001355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T13:46:12Z","timestamp":1725803172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841124001355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":23,"alternative-id":["S0896841124001355"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2024.103301","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of biologic immunosuppressants in pregnant women with immune-mediated inflammatory diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2024.103301","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103301"}}